Zhejiang Xianju Pharmaceutical Co.,Ltd. (SHE:002332)
China flag China · Delayed Price · Currency is CNY
9.14
+0.04 (0.44%)
Feb 3, 2026, 3:04 PM CST

SHE:002332 Income Statement

Millions CNY. Fiscal year is Jan - Dec.
Fiscal Year
TTMFY 2024FY 2023FY 2022FY 2021FY 2020
Period Ending
Sep '25 Dec '24 Dec '23 Jan '23 Jan '22 Dec '20
Operating Revenue
3,5683,9804,0794,3584,3354,002
Other Revenue
21.1721.1743.9621.5222.4616.91
3,5894,0014,1234,3804,3574,019
Revenue Growth (YoY)
-12.95%-2.98%-5.85%0.52%8.42%8.37%
Cost of Revenue
1,3411,7441,9721,8651,8481,801
Gross Profit
2,2492,2562,1522,5152,5092,218
Selling, General & Admin
1,4871,3441,2711,5321,5601,344
Research & Development
278.85265.17261266.77243.37208.39
Other Operating Expenses
25.8619.2622.0432.9232.7334.43
Operating Expenses
1,8011,6391,5471,8361,8361,578
Operating Income
447.51617.42604.79678.81672.92640.05
Interest Expense
-4.97-3.13-3.37-6.29-23.1-49.23
Interest & Investment Income
4.9729.4838.2876.5443.1914.97
Currency Exchange Gain (Loss)
10.5710.57-9.3211.817.44-25.01
Other Non Operating Income (Expenses)
-10.91-2.7-5.53-11.25-5.26-18.64
EBT Excluding Unusual Items
447.17651.63624.85749.6705.19562.13
Gain (Loss) on Sale of Investments
-20.39-8.14-8.97-00.64-
Gain (Loss) on Sale of Assets
47.280.28-1.4891.6214.51-0.74
Asset Writedown
-1.96-1.31-0.42-0.91-1.68-1.12
Other Unusual Items
-170.81-170.8127.731.5811.232.36
Pretax Income
327.97498.33641.68871.89729.87621.25
Income Tax Expense
74.8798.479.56124.49108.692.25
Earnings From Continuing Operations
253.1399.92562.12747.4621.26529
Minority Interest in Earnings
20.59-2.740.972.01-1.94-24.49
Net Income
273.68397.18563.08749.41619.33504.51
Net Income to Common
273.68397.18563.08749.41619.33504.51
Net Income Growth
-55.98%-29.46%-24.86%21.00%22.76%22.94%
Shares Outstanding (Basic)
993993988989989917
Shares Outstanding (Diluted)
993993988989989917
Shares Change (YoY)
0.54%0.51%-0.13%0.00%7.84%0.59%
EPS (Basic)
0.280.400.570.760.630.55
EPS (Diluted)
0.280.400.570.760.630.55
EPS Growth
-56.21%-29.83%-24.76%21.00%13.84%22.22%
Free Cash Flow
104.27191.07360.85326.74409.31671.06
Free Cash Flow Per Share
0.100.190.360.330.410.73
Dividend Per Share
0.4000.3000.3000.3000.1500.150
Dividend Growth
33.33%--100.00%-50.00%
Gross Margin
62.64%56.40%52.18%57.42%57.58%55.18%
Operating Margin
12.47%15.43%14.67%15.50%15.44%15.93%
Profit Margin
7.63%9.93%13.66%17.11%14.21%12.55%
Free Cash Flow Margin
2.90%4.78%8.75%7.46%9.39%16.70%
EBITDA
670.11835.24816.24866.26857.11817.16
EBITDA Margin
18.67%20.88%19.79%19.78%19.67%20.33%
D&A For EBITDA
222.6217.82211.45187.46184.19177.11
EBIT
447.51617.42604.79678.81672.92640.05
EBIT Margin
12.47%15.43%14.67%15.50%15.44%15.93%
Effective Tax Rate
22.83%19.75%12.40%14.28%14.88%14.85%
Revenue as Reported
3,5894,0014,1234,3804,3574,019
Advertising Expenses
-712.54685.06991.031,035864.56
Source: S&P Global Market Intelligence. Standard template. Financial Sources.